Makeup softness isn’t the problem, per se, in L’Oreal’s sluggish US business, which is fixable with sharper innovation and execution driven by a newly instated leadership team, CEO Jean-Paul Agon says. L’Oreal’s overall global sales in fiscal 2019 to date are up 7.5%, like-for-like, after continued strong momentum in its fiscal 2019 third quarter.
L'Oreal SA is looking to new leadership to energize its US business, where makeup overexposure has dragged on its North American sales – virtually “the only weakness in the picture,” the beauty giant says.
Sales in North America slipped 1.3%, like-for-like, to roughly €1.9bn ($2.1bn) in the fiscal 2019 third quarter, according to the...
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
CEO Sue Nabi says Coty has created a “multi-functional, stand-alone organization” within its Consumer Beauty business to drive rapid-fire innovation. In a 20 August presentation, Nabi said the firm’s innovation pipeline undergirds its fiscal 2025 outlook of 6%-8% growth.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
